Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Hevolution'sexecutiveteamincludes,fromleft,SophiaPathai,HayaBintKhaledBinBandarAlSaud,MehmoodKhan,an DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr




entertainment

author：hotspot    Page View：41946
A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

Next stop: Beacon Hill.

Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

advertisement

But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： The EPA's new lead rule: How one expert crunched the numbers
Next article： Virginia high school admissions case could be legal follow